Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorPennington Biomedical Research Center

About this trial

The objective of this study is to assess the effects of Hass Avocados on glycemic control. The investigators hypothesize that Hass Avocado consumption will reduce fasting blood sugar compared to an isocaloric amount of other fruit during controlled feeding.

Eligibility criteria

Qualifiers

Participant reported diagnosis of Type 2 diabetes

HbA1c between 5.7%-11% (inclusive) and / or fasting blood glucose of ≥ 100 mg/dL

BMI 27-50 kg/m2 (inclusive)

Age range - 18 - 65 years (inclusive)

Disqualifiers

Not willing or unable to consume study foods including avocados

Participation in a weight control program within the past 3 months or weight loss of ≥ 5 kg in the previous 3 months

Taking prescription or OTC weight loss medications within last 4 weeks

History of a surgical procedure for weight loss in last 5 years (e.g. gastroplasty, gastric by-pass, gastrectomy or partial gastrectomy, adjustable banding, gastric sleeve)

Trial design

Treatments tested in this trial

  • Avocado
  • Other Fruit(s)

Treatment groups

48 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Pennington Biomedical Research Center

Lead sponsor

Prachi Singh

Collaborator

Frank L. Greenway

Collaborator

Robbie A. Beyl

Collaborator